Show simple item record

Impact of diabetes, insulin, and metformin use on the outcome of patients with human epidermal growth factor receptor 2–positive primary breast cancer: analysis from the altto phase iii randomized trial

dc.contributor.authorSonnenblick, Amir
dc.contributor.authorAgbor-Tarh, Dominique
dc.contributor.authorBradbury, Ian
dc.contributor.authorDi Cosimo, Serena
dc.contributor.authorAzim, Hatem A.
dc.contributor.authorFumagalli, Debora
dc.contributor.authorSarp, Severine
dc.contributor.authorWolff, Antonio C.
dc.contributor.authorAndersson, Michael
dc.contributor.authorKroep, Judith
dc.contributor.authorCufer, Tanja
dc.contributor.authorSimon, Sergio D.
dc.contributor.authorSalman, Pamela
dc.contributor.authorToi, Masakazu
dc.contributor.authorHarris, Lyndsay
dc.contributor.authorGralow, Julie
dc.contributor.authorKeane, Maccon
dc.contributor.authorMoreno-Aspitia, Alvaro
dc.contributor.authorPiccart-Gebhart, Martine
dc.contributor.authorde Azambuja, Evandro
dc.date.accessioned2018-09-20T16:25:16Z
dc.date.available2018-09-20T16:25:16Z
dc.date.issued2017-05-01
dc.identifier.citationSonnenblick, Amir; Agbor-Tarh, Dominique; Bradbury, Ian; Di Cosimo, Serena; Azim, Hatem A. Fumagalli, Debora; Sarp, Severine; Wolff, Antonio C.; Andersson, Michael; Kroep, Judith; Cufer, Tanja; Simon, Sergio D.; Salman, Pamela; Toi, Masakazu; Harris, Lyndsay; Gralow, Julie; Keane, Maccon; Moreno-Aspitia, Alvaro; Piccart-Gebhart, Martine; de Azambuja, Evandro (2017). Impact of diabetes, insulin, and metformin use on the outcome of patients with human epidermal growth factor receptor 2–positive primary breast cancer: analysis from the altto phase iii randomized trial. Journal of Clinical Oncology 35 (13),
dc.identifier.issn0732-183X,1527-7755
dc.identifier.urihttp://hdl.handle.net/10379/13984
dc.publisherAmerican Society of Clinical Oncology (ASCO)
dc.relation.ispartofJournal of Clinical Oncology
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Ireland
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/3.0/ie/
dc.subjectmediates trastuzumab resistance
dc.subjectadjuvant chemotherapy
dc.subjecther2+breast cancer
dc.subjectcell-growth
dc.subjectsurvival
dc.subjectactivation
dc.subjectstat3
dc.subjectwomen
dc.subjectassociations
dc.subjectpopulation
dc.titleImpact of diabetes, insulin, and metformin use on the outcome of patients with human epidermal growth factor receptor 2–positive primary breast cancer: analysis from the altto phase iii randomized trial
dc.typeArticle
dc.identifier.doi10.1200/jco.2016.69.7722
dc.local.publishedsourcehttp://europepmc.org/articles/pmc5455460?pdf=render
nui.item.downloads0


Files in this item

Thumbnail
Name:
license.txt
Size:
5.659Kb
Format:
Text file
View/Open

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Ireland
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Ireland